請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43473完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 楊偉勛 | |
| dc.contributor.author | Ya-Fang Chen | en |
| dc.contributor.author | 陳雅芳 | zh_TW |
| dc.date.accessioned | 2021-06-15T02:22:09Z | - |
| dc.date.available | 2009-09-15 | |
| dc.date.copyright | 2009-09-15 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-08-19 | |
| dc.identifier.citation | 1. Brown EM, MacLeod RJ: Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001, 81:239-297.
2. Thakker RV: Genetic developments in hypoparathyroidism. Lancet 2001, 357:974-976. 3. Cuneo BF: 22q11.2 deletion syndrome: DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes. Curr Opin Pediatr 2001, 13:465-472. 4. Parvari R, Hershkovitz E, Grossman N, Gorodischer R, Loeys B, Zecic A, Mortier G, Gregory S, Sharony R, Kambouris M, et al: Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome. Nat Genet 2002, 32:448-452. 5. Tengan CH, Kiyomoto BH, Rocha MS, Tavares VL, Gabbai AA, Moraes CT: Mitochondrial encephalomyopathy and hypoparathyroidism associated with a duplication and a deletion of mitochondrial deoxyribonucleic acid. J Clin Endocrinol Metab 1998, 83:125-129. 6. Bjorses P, Halonen M, Palvimo JJ, Kolmer M, Aaltonen J, Ellonen P, Perheentupa J, Ulmanen I, Peltonen L: Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet 2000, 66:378-392. 7. Trump D, Dixon PH, Mumm S, Wooding C, Davies KE, Schlessinger D, Whyte MP, Thakker RV: Localisation of X linked recessive idiopathic hypoparathyroidism to a 1.5 Mb region on Xq26-q27. J Med Genet 1998, 35:905-909. 8. Miric A, Levine MA: Analysis of the preproPTH gene by denaturing gradient gel electrophoresis in familial isolated hypoparathyroidism. J Clin Endocrinol Metab 1992, 74:509-516. 9. Pollak MR, Brown EM, Estep HL, McLaine PN, Kifor O, Park J, Hebert SC, Seidman CE, Seidman JG: Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet 1994, 8:303-307. 10. Zajac JD, Danks JA: The development of the parathyroid gland: from fish to human. Curr Opin Nephrol Hypertens 2008, 17:353-356. 11. Gunther T, Chen ZF, Kim J, Priemel M, Rueger JM, Amling M, Moseley JM, Martin TJ, Anderson DJ, Karsenty G: Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature 2000, 406:199-203. 12. Liu Z, Yu S, Manley NR: Gcm2 is required for the differentiation and survival of parathyroid precursor cells in the parathyroid/thymus primordia. Dev Biol 2007, 305:333-346. 13. Okabe M, Graham A: The origin of the parathyroid gland. Proc Natl Acad Sci U S A 2004, 101:17716-17719. 14. Ding C, Buckingham B, Levine MA: Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB. J Clin Invest 2001, 108:1215-1220. 15. Thomee C, Schubert SW, Parma J, Le PQ, Hashemolhosseini S, Wegner M, Abramowicz MJ: GCMB mutation in familial isolated hypoparathyroidism with residual secretion of parathyroid hormone. J Clin Endocrinol Metab 2005, 90:2487-2492. 16. Maret A, Ding C, Kornfield SL, Levine MA: Analysis of the GCM2 gene in isolated hypoparathyroidism: a molecular and biochemical study. J Clin Endocrinol Metab 2008, 93:1426-1432. 17. Kebebew E, Peng M, Wong MG, Ginzinger D, Duh QY, Clark OH: GCMB gene, a master regulator of parathyroid gland development, expression, and regulation in hyperparathyroidism. Surgery 2004, 136:1261-1266. 18. Neubuser A, Koseki H, Balling R: Characterization and developmental expression of Pax9, a paired-box-containing gene related to Pax1. Dev Biol 1995, 170:701-716. 19. Peters H, Neubuser A, Kratochwil K, Balling R: Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities. Genes Dev 1998, 12:2735-2747. 20. Su D, Ellis S, Napier A, Lee K, Manley NR: Hoxa3 and pax1 regulate epithelial cell death and proliferation during thymus and parathyroid organogenesis. Dev Biol 2001, 236:316-329. 21. Zou D, Silvius D, Davenport J, Grifone R, Maire P, Xu PX: Patterning of the third pharyngeal pouch into thymus/parathyroid by Six and Eya1. Dev Biol 2006, 293:499-512. 22. Manley NR, Capecchi MR: The role of Hoxa-3 in mouse thymus and thyroid development. Development 1995, 121:1989-2003. 23. Kameda Y, Arai Y, Nishimaki T, Chisaka O: The role of Hoxa3 gene in parathyroid gland organogenesis of the mouse. J Histochem Cytochem 2004, 52:641-651. 24. Ivins S, Lammerts van Beuren K, Roberts C, James C, Lindsay E, Baldini A, Ataliotis P, Scambler PJ: Microarray analysis detects differentially expressed genes in the pharyngeal region of mice lacking Tbx1. Dev Biol 2005, 285:554-569. 25. Wurdak H, Ittner LM, Sommer L: DiGeorge syndrome and pharyngeal apparatus development. Bioessays 2006, 28:1078-1086. 26. Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous RW, Holdaway I, et al: GATA3 haplo-insufficiency causes human HDR syndrome. Nature 2000, 406:419-422. 27. Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, Grosveld FG, Engel JD, Lindenbaum MH: Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat Genet 1995, 11:40-44. 28. Kronenberg HM: GCMB--another serendipitous gift from evolution to clinical investigators. J Clin Endocrinol Metab 2004, 89:6-7. 29. Kammerer M, Pirola B, Giglio S, Giangrande A: GCMB, a second human homolog of the fly glide/gcm gene. Cytogenet Cell Genet 1999, 84:43-47. 30. Akiyama Y, Hosoya T, Poole AM, Hotta Y: The gcm-motif: a novel DNA-binding motif conserved in Drosophila and mammals. Proc Natl Acad Sci U S A 1996, 93:14912-14916. 31. Mannstadt M, Bertrand G, Muresan M, Weryha G, Leheup B, Pulusani SR, Grandchamp B, Juppner H, Silve C: Dominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism. J Clin Endocrinol Metab 2008, 93:3568-3576. 32. Canaff L, Zhou X, Mosesova I, Cole DE, Hendy GN: Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism. Hum Mutat 2009, 30:85-92. 33. Baumber L, Tufarelli C, Patel S, King P, Johnson CA, Maher ER, Trembath RC: Identification of a novel mutation disrupting the DNA binding activity of GCM2 in autosomal recessive familial isolated hypoparathyroidism. J Med Genet 2005, 42:443-448. 34. Marx SJ: Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000, 343:1863-1875. 35. 林興中: 低血鈣症之處理。. 臺灣醫界 1994, 37:57-65. 36. Nakamura Y, Matsumoto T, Tamakoshi A, Kawamura T, Seino Y, Kasuga M, Yanagawa H, Ohno Y: Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol 2000, 10:29-33. 37. Paul S Thornton M, MCh, MRCPI, Andrea Kelly, MD, Michael Willcutts,MD,: Hypoparathyroidism. Jul 26,2006. 38. Chiu WY, Chen HW, Chao HW, Yann LT, Tsai KS: Identification of three novel mutations in the GATA3 gene responsible for familial hypoparathyroidism and deafness in the Chinese population. J Clin Endocrinol Metab 2006, 91:4587-4592. 39. Sticht H, Hashemolhosseini S: A common structural mechanism underlying GCMB mutations that cause hypoparathyroidism. Med Hypotheses 2006, 67:482-487. 40. D'Souza-Li L: The calcium-sensing receptor and related diseases. Arq Bras Endocrinol Metabol 2006, 50:628-639. 41. Hirai H, Nakajima S, Miyauchi A, Nishimura K, Shimizu N, Shima M, Michigami T, Ozono K, Okada S: A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia. J Hum Genet 2001, 46:41-44. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43473 | - |
| dc.description.abstract | 副甲狀腺功能低下症(hypoparathyroidism, HP)的特徵是低血鈣和高血磷,由於PTH的分泌不足或缺乏所造成的。單一家族性副甲狀腺功能低下(Familial isolated hypoparathyroidism )可能由幾種基因突變有關,如:GCMB 基因(MIN 603716)、CaSR 基因 (MIN 601199)、GATA3基因(MIN131320)、PTH 基因(MIN 168450)。遺傳模式為自體顯性(autosomoal dominant)、自體隱性(autosomoal recessive)或X染色體連鎖(X chromosome-linked)遺傳。從文獻得知GCMB是一種轉錄因子,且在副甲狀腺的發育扮演重要的角色。故本研究是以一個HP家族中兩位已知檢測過CaSR和GATA3基因的HP病患,取週邊血液萃取total DNA,進行所有GCMB的外顯子(exon)的序列分析。結果發現其中一位病患在exon 5 第323鹽基位置的C轉變成T,此點突變轉錄後並未改變胺基酸,所以此病患的GCMB的exon 5上的突變與HP是沒有關係的。由於這兩位病患已檢測過GCMB 、CaSR及GATA3基因,未來希望能分析與副甲狀腺發育相關的基因突變,藉此建立基因檢測與遺傳諮詢模式。 | zh_TW |
| dc.description.abstract | Hypoparathyroidium (HP) is characterized by hypocalcemia and hyperphosphatemia due to deficient or absent secretion of parathyroid hormone (PTH). Familial isolated hypoparathyroidism (FIH) is associated with the mutation of several gene, including GCMB (MIN 603716), CaSR (MIN 601199), GATA3 (MIN 131320), and PTH (MIN 168450). FIH could be autosomoal dominant, autosomal recessive or X choromosome-linked in mode of inheritance. GCMB is identified as a transcription factor and plays a role in parathyroid gland development. Our study was to examine the GCMB gene in two HP patients of a HP family, who CaSR and GATA3 have been found to have no mutations. We identified a C to T at nucleotide position 323 in exon 5, present in one HP patient, and this point mutation was a nonsense mutation, so exon 5 of GCMB mutation in HP patient was not associated with HP. In future, we win analyze sequence of the other gene that are involved in the development of the parathyroid glands, and then establish a model of mutation detection and genetic counseling. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T02:22:09Z (GMT). No. of bitstreams: 1 ntu-98-P96448014-1.pdf: 1871858 bytes, checksum: fecd3464886dd20af41b570877c7a57c (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | 目錄
口試委員審定書 Ⅰ 誌謝 Ⅱ 中文摘要 Ⅶ Abstract Ⅷ 第一章 緒論 1 1.1 背景介紹 1 1.2 副甲狀腺的基因調控 1 1.3 GCMB基因介紹 3 1.4 副甲狀腺的功能 4 1.5 臨床特徵 5 1.6 診斷與治療 5 1.7 盛行率 5 1.8 研究動機及目的 5 第二章 實驗材料與研究方法 6 2.1. 實驗材料 6 2.1.1 實驗對象 6 2.1.2引子之設計 6 2.1.3各項實驗所需試劑 7 2.2研究方法 7 2.2.1血液檢體DNA萃取過程 7 2.2.2聚合酶連鎖反應 8 2.2.3洋菜膠體之配製 9 2.2.4電泳條件 9 2.2.5基因定序分析 10 2.2.6序列表對 10 第三章 實驗結果 11 3.1家族圖譜 11 3.2 GCMB突變確認 11 第四章 討論 12 4.1家族圖譜之探討 12 3.2 GCMB突變分析之探討 12 第五章 結論 13 第六章 參考文獻 36 附錄 39 圖目錄 圖一. GCMB基因與蛋白質結構. 14 圖二. GCMB 基因外顯子與引子位置圖. 15 圖三. 病患的家族圖譜. 16 圖四. P1病患GCMB exon 1序列與NCBI比對結果. 17 圖五. P2病患GCMB exon 1序列與NCBI比對結果。. 18 圖六. P1病患GCMB exon 2序列與NCBI比對結果. 19 圖七. P2病患GCMB exon 2序列與NCBI比對結果. 20 圖八. P1病患GCMB exon 3序列與NCBI比對結果. 21 圖九. P2病患GCMB exon 3序列與NCBI比對結果. 22 圖十. P1病患GCMB exon 4序列與NCBI比對結果. 23 圖十一. P2病患GCMB exon 4序列與NCBI比對結果 24 圖十二. P1病患GCMB exon 5序列與NCBI比對結果 25 圖十三. P2病患GCMB exon 5序列與NCBI比對結果. 27 圖十四. P2病患exon 5序列突變位置... 29 表目錄 表一. 常見HP的相關基因. 30 表二. 調控副甲狀腺發育的相關基因 31 表三. 導致HP的GCMB突變位置 32 表三. 為本實驗所選定的基因座位置及引子的序列 33 表四. P1病患的檢驗報告. 34 | |
| dc.language.iso | zh-TW | |
| dc.subject | 低血鈣 | zh_TW |
| dc.subject | 家族性副甲狀腺功能低下 | zh_TW |
| dc.subject | GCMB基因 | zh_TW |
| dc.subject | GCMB gene | en |
| dc.subject | hypocalcemia | en |
| dc.subject | familial hypoparathyroidism | en |
| dc.title | 家族性副甲狀腺功能低下之GCMB基因分析 | zh_TW |
| dc.title | Analysis of the GCMB gene for family hypoparathyroidism | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 蔡克嵩,蘇怡寧 | |
| dc.subject.keyword | 家族性副甲狀腺功能低下,低血鈣,GCMB基因, | zh_TW |
| dc.subject.keyword | familial hypoparathyroidism,hypocalcemia,GCMB gene, | en |
| dc.relation.page | 49 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2009-08-19 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 分子醫學研究所 | zh_TW |
| 顯示於系所單位: | 分子醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 未授權公開取用 | 1.83 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
